New evidence
A systematic review found synbiotic treatments linked to reduced painkiller use in migraine — alongside cuts in frequency, severity, and duration — though the evidence comes from only six, mostly small trials.
This is early but promising evidence that targeting the gut microbiome with pre- and probiotics might help manage migraine, but with few studies and no specified dose or long-term data, it's far from a settled recommendation.
The review looked at the gut bacteria of people with migraine and found they tend to have less diverse microbiomes than healthy controls. It also pooled results from six trials showing that taking synbiotics (a mix of prebiotics and probiotics) significantly reduced how often migraines hit, how bad they were, how long they lasted, and how much pain medication people needed. Because the total number of trials is small and the exact bacteria strains and doses varied, these effects need confirmation in larger, more standardized studies.
Where this fits in the evidence
This is among the first studies we've indexed on Streptococcus thermophilus PXN 66 for Reduced Painkiller Consumption — treat it as an early signal until more research accumulates.
The study
Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiome.
- Systematic Review
- 2025-05-21
- The journal of headache and pain
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.